Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation

NCT: NCT04685317 · RECRUITING

NCT IDNCT04685317
StatusRECRUITING
Start Date2023-03-07
Completion2027-06
SponsorMalini Madhavan (OTHER)
First posted
Last updated

Brief Summary

The purpose of the study is to see if the Sentinel® Cerebral Protection System may prevent occurrence of stroke during an ablation procedure for atrial fibrillation (AF). The secondary purpose of this study is to study if cognitive function after AF ablation differs between those treated with the Sentinel cerebral protection device and those who do not receive the device.

Frequently Asked Questions

What is Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation?

Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation is a clinical trial registered under NCT04685317. Current status: RECRUITING.

What is the status of NCT04685317?

The current status of NCT04685317 (Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation) is: RECRUITING.

When did Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation start?

Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation started on 2023-03-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑